Building control arms for cancer clinical trials from real-world data Published June 2019 Citation Bennette, CS, Segal, BD, Miksad, RA, Bellomo, L, Nussbaum, NC, Sarkar, S, Tucker, MG, Abernethy, AP. . HTAi. . https://htai.org/wp-content/uploads/2019/08/htai_AM19_abstracts_20190812.pdf#page=14 Authors:Bennette, CS, Segal, BD, Miksad, RA, Bellomo, L, Nussbaum, NC, Sarkar, S, Tucker, MG, Abernethy, AP Sources:HTAi Share Posted inPublicationsMethodology More publicationsISPORApril 2025Analytical approaches to estimate medication persistence from EHR data: a study of TKIs in patients with EGFR+ advanced NSCLCLi X, Jarrett B, Kerr B, et al. Real-world evidencePublication summaryPublicationsMethodologyNon-small cell lung cancerESMO Real-World Data and Digital OncologyFebruary 2025Characterisation of oncology EHR-derived real-world data in the UK, Germany, and JapanAdamson B, Horne E, Xu C, et al.Real-world evidencePublication summaryPublicationsData scienceMethodologyHTA and market accessFrontiers in Drug Safety and RegulationAugust 2024Measurement error and bias in real-world oncology endpoints when constructing external control armsAckerman B, Gan R, Meyer C, et al. Publication summaryPublicationsMethodologyMultiple myeloma